Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
- PMID: 26399219
- PMCID: PMC4721602
- DOI: 10.1002/gepi.21921
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
Abstract
Epithelial-mesenchymal transition (EMT) is a process whereby epithelial cells assume mesenchymal characteristics to facilitate cancer metastasis. However, EMT also contributes to the initiation and development of primary tumors. Prior studies that explored the hypothesis that EMT gene variants contribute to epithelial ovarian carcinoma (EOC) risk have been based on small sample sizes and none have sought replication in an independent population. We screened 15,816 single-nucleotide polymorphisms (SNPs) in 296 genes in a discovery phase using data from a genome-wide association study of EOC among women of European ancestry (1,947 cases and 2,009 controls) and identified 793 variants in 278 EMT-related genes that were nominally (P < 0.05) associated with invasive EOC. These SNPs were then genotyped in a larger study of 14,525 invasive-cancer patients and 23,447 controls. A P-value <0.05 and a false discovery rate (FDR) <0.2 were considered statistically significant. In the larger dataset, GPC6/GPC5 rs17702471 was associated with the endometrioid subtype among Caucasians (odds ratio (OR) = 1.16, 95% CI = 1.07-1.25, P = 0.0003, FDR = 0.19), whereas F8 rs7053448 (OR = 1.69, 95% CI = 1.27-2.24, P = 0.0003, FDR = 0.12), F8 rs7058826 (OR = 1.69, 95% CI = 1.27-2.24, P = 0.0003, FDR = 0.12), and CAPN13 rs1983383 (OR = 0.79, 95% CI = 0.69-0.90, P = 0.0005, FDR = 0.12) were associated with combined invasive EOC among Asians. In silico functional analyses revealed that GPC6/GPC5 rs17702471 coincided with DNA regulatory elements. These results suggest that EMT gene variants do not appear to play a significant role in the susceptibility to EOC.
Keywords: epithelial-mesenchymal transition; ovarian cancer; single-nucleotide polymorphisms.
© 2015 WILEY PERIODICALS, INC.
Conflict of interest statement
The co-authors have no conflicts of interest to declare.
Figures

References
-
- American Cancer Society. Cancer Facts and Figures 2014. Atlanta: American Cancer Society; 2014.
-
- De Cat B, David G. Developmental roles of the glypicans. Semin Cell Dev Biol. 2001;12:117–125. - PubMed
Publication types
MeSH terms
Grants and funding
- 1K99CA184415-01/CA/NCI NIH HHS/United States
- R01 CA074850/CA/NCI NIH HHS/United States
- C490/A10124/CRUK_/Cancer Research UK/United Kingdom
- P30 CA008748/CA/NCI NIH HHS/United States
- P30 CA076292/CA/NCI NIH HHS/United States
- R03 CA115195/CA/NCI NIH HHS/United States
- R01 CA076016/CA/NCI NIH HHS/United States
- U19 CA148112/CA/NCI NIH HHS/United States
- U01 CA049449/CA/NCI NIH HHS/United States
- U01 CA069417/CA/NCI NIH HHS/United States
- R01 CA050385/CA/NCI NIH HHS/United States
- N01 PC067010/PC/NCI NIH HHS/United States
- C490/A6187/CRUK_/Cancer Research UK/United Kingdom
- P30 CA016056/CA/NCI NIH HHS/United States
- R01 CA087538/CA/NCI NIH HHS/United States
- R01 CA136924/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- P30 CA072720/CA/NCI NIH HHS/United States
- C490/A10119/CRUK_/Cancer Research UK/United Kingdom
- K99 CA184415/CA/NCI NIH HHS/United States
- R03 CA113148/CA/NCI NIH HHS/United States
- R01 CA058598/CA/NCI NIH HHS/United States
- K22 CA138563/CA/NCI NIH HHS/United States
- R01 CA058860/CA/NCI NIH HHS/United States
- R01 CA080742/CA/NCI NIH HHS/United States
- T32ES013678/ES/NIEHS NIH HHS/United States
- R01 CA063678/CA/NCI NIH HHS/United States
- K07 CA092044/CA/NCI NIH HHS/United States
- P50 CA105009/CA/NCI NIH HHS/United States
- U01 CA067262/CA/NCI NIH HHS/United States
- R25 CA147832/CA/NCI NIH HHS/United States
- P30 CA014089/CA/NCI NIH HHS/United States
- MOP-86727/CAPMC/ CIHR/Canada
- R25T CA147832/CA/NCI NIH HHS/United States
- R01 CA083918/CA/NCI NIH HHS/United States
- R01 CA054419/CA/NCI NIH HHS/United States
- R01 CA122443/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- R01 CA-1491429/CA/NCI NIH HHS/United States
- K07 CA143047/CA/NCI NIH HHS/United States
- R01 CA087696/CA/NCI NIH HHS/United States
- U01 CA058860/CA/NCI NIH HHS/United States
- T32 ES013678/ES/NIEHS NIH HHS/United States
- R01 CA149429/CA/NCI NIH HHS/United States
- P01 CA017054/CA/NCI NIH HHS/United States
- N01 CN025403/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- R01 CA063682/CA/NCI NIH HHS/United States
- R01-CA076016/CA/NCI NIH HHS/United States
- UM1 CA182910/CA/NCI NIH HHS/United States
- K07 CA095666/CA/NCI NIH HHS/United States
- P30 CA071789/CA/NCI NIH HHS/United States
- R01 CA112523/CA/NCI NIH HHS/United States
- P50 CA136393/CA/NCI NIH HHS/United States
- R01 CA126841/CA/NCI NIH HHS/United States
- R01 CA114343/CA/NCI NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
- N01 PC035137/PC/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous